Unresectable Locally Advanced Pancreatic Cancer: Treatment With Neoadjuvant Leucovorin, Fluorouracil, Irinotecan, and Oxaliplatin and Assessment of Surgical Resectability

被引:9
|
作者
Mondo, Esther Liu [1 ]
Noel, Marcus S. [2 ]
Katz, Alan W. [2 ]
Schoeniger, Luke O. [2 ]
Hezel, Aram F. [2 ]
机构
[1] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14627 USA
[2] Univ Rochester, Med Ctr, Sch Med & Dent, James P Wilmot Canc Ctr, Rochester, NY 14642 USA
关键词
CHEMOTHERAPY; GEMCITABINE;
D O I
10.1200/JCO.2012.44.0339
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:E37 / E39
页数:3
相关论文
共 50 条
  • [21] Locally Advanced Pancreatic Cancer Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients
    Hackert, Thilo
    Sachsenmaier, Milena
    Hinz, Ulf
    Schneider, Lutz
    Michalski, Christoph W.
    Springfeld, Christoph
    Strobel, Oliver
    Jaeger, Dirk
    Ulrich, Alexis
    Buechler, Markus W.
    ANNALS OF SURGERY, 2016, 264 (03) : 457 - 463
  • [22] Neoadjuvant modified FOLFIRINOX and chemoradiation therapy for locally advanced pancreatic cancer improves resectability
    Nanda, Ronica H.
    El-Rayes, Bassel
    Maithel, Shishir K.
    Landry, Jerome
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (08) : 1028 - 1034
  • [23] Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
    Andre, T
    Boni, C
    Mounedji-Boudiaf, L
    Navarro, M
    Tabernero, J
    Hickish, T
    Topham, C
    Zaninelli, M
    Clingan, P
    Bridgewater, J
    Tabah-Fisch, I
    de Gramont, A
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23): : 2343 - 2351
  • [24] Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer
    Klautke, G
    Feyerherd, P
    Ludwig, K
    Prall, F
    Foitzik, T
    Fietkau, R
    BRITISH JOURNAL OF CANCER, 2005, 92 (07) : 1215 - 1220
  • [25] Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer
    G Klautke
    P Feyerherd
    K Ludwig
    F Prall
    T Foitzik
    R Fietkau
    British Journal of Cancer, 2005, 92 : 1215 - 1220
  • [26] FOLFOX (oxaliplatin and leucovorin plus fluorouracil) versus FOLFIRI (irinotecan and leucovorin plus fluorouracil) chemotherapy as a first-line treatment in a patients with unresectable metastatic or recurred gastric adenocarcinoma
    Tak, Dae Hyun
    Kim, Seok Hyun
    Moon, Hee Seok
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 261 - 261
  • [27] Irinotecan combined with leucovorin-5-fluorouracil in the treatment of advanced colorectal cancer.
    Rigatos, SK
    Stathopoulos, GP
    Nacos, A
    Stathopoulos, J
    Pergantas, N
    Athanassiadis, I
    ANNALS OF ONCOLOGY, 2000, 11 : 56 - 56
  • [28] Locally Advanced Unresectable Pancreatic Cancer
    Johung, Kimberly L.
    Saif, Muhammad Wasif
    Chang, Bryan W.
    JOURNAL OF THE PANCREAS, 2014, 15 (04): : 329 - 331
  • [29] Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX
    Michelakos, Theodoros
    Pergolini, Ilaria
    Fernandez-del Castillo, Carlos
    Honselmann, Kim C.
    Cai, Lei
    Deshpande, Vikram
    Wo, Jennifer Y.
    Ryan, David P.
    Allen, Jill N.
    Blaszkowsky, Lawrence S.
    Clark, Jeffrey W.
    Murphy, Janet E.
    Nipp, Ryan D.
    Parikh, Aparna
    Qadan, Motaz
    Warshaw, Andrew L.
    Hong, Theodore S.
    Lillemoe, Keith D.
    Ferrone, Cristina R.
    ANNALS OF SURGERY, 2019, 269 (04) : 733 - 740
  • [30] Predictors of Resectability and Survival in Patients with Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment with FOLFIRINOX
    Hu, Hai-Jie
    Li, Fu-Yu
    ANNALS OF SURGERY, 2018, 268 (06) : E95 - E96